CJC-1295 Without DAC (10mg) protocols focus on this synthetic growth hormone-releasing hormone (GHRH) analog designed for shorter-acting stimulation of natural growth hormone (GH) pulses. Unlike the DAC version, this form has a shorter half-life, allowing more controlled and physiologic GH release patterns. It is often used to support recovery, lean muscle development, and improved sleep quality. This guide outlines a subcutaneous administration approach optimized for the 10 mg vial format.
Concise summary of the subcutaneous regimen.
Suggested approach for the 10 mg vial format.
CJC-1295 Without DAC is a modified analog of growth hormone-releasing hormone (GHRH) that binds to receptors in the pituitary gland, stimulating the natural release of growth hormone (GH).
Because it lacks Drug Affinity Complex (DAC), it has a shorter half-life and produces more natural, pulsatile GH release rather than prolonged elevation. This mimics the body’s natural rhythm of GH secretion, which plays a role in muscle growth, fat metabolism, cellular repair, and recovery. It may also increase levels of IGF-1 (Insulin-like Growth Factor 1), a key mediator of GH effects.
Observations based on preclinical and early-stage research.
Potential Benefits:
Possible Side Effects: